4//SEC Filing
Caissa Capital Management ltd. 4
Accession 0001929354-23-000016
CIK 0001534120other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:10 PM ET
Size
7.0 KB
Accession
0001929354-23-000016
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-06-26$0.64/sh−1,425,700$917,153→ 0 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-26$0.62/sh−182,300$113,026→ 0 total
Footnotes (3)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.45 to $0.84, inclusive.
- [F3]These shares are directly owned by Mr. Golestaneh in his personal capacity.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001929354
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:10 PM ET
- Size
- 7.0 KB